Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population

Anticancer Research

Volumn 23, Issue 3 C, 2003, Pages 2897-2902

  Nakazato, Haruki ^a   Suzuki, Kazuhiro ^a   Matsui, Hiroshi ^a   Koike, Hidekazu ^a   Okugi, Hironobu ^a   Ohtake, Nobuaki ^a   Takei, Tomoyuki ^a   Nakata, Seiji ^a   Hasumi, Masaru ^a   Kazuto, Ito ^a   Kurokawa, Kohei ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Familial prostate cancer; Genetic polymorphism; GST

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL CANCER; GENE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; GLUTATHIONE S TRANSFERASE M1 GENE; GLUTATHIONE S TRANSFERASE P1 GENE; GLUTATHIONE S TRANSFERASE T1 GENE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RISK ASSESSMENT; STRATIFICATION;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS;

EID: 0042123564     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Smith JR, Freije D, Carpten JD, Grongerg M, Xu J, Issacs SD, Brownstein MJ, Bova GS Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM and Isaacs WB: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 274: 1371-1374, 1996.
2. Berthon P, Valeri A, Cohen-Akenine A, Drelon E, Paiss T, Wohr G and Latil A: Predisposing gene for early-onset prostate cancer, localized on chromosome lq42.2-43. Am J Hum Genet 62: 1416-1424, 1998.
3. Xu J, Mayers D, Freije D, Issacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Issacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallionimi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M and Thibodeau S and Trent J: Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20: 175-179, 1998.
4. Gibbs M, Stanford JL, Mclndoe TA, Jarvik GP, Kolb S, Goode EL, Chakrabarti L, Schuster EF, Buckley VA, Miller EL, Brandzel S, Li S, Hood L and Ostrander EA: Evidence for a rare prostate cancer-susceptibility locus at chromosome lp36. Am J Hum Genet 64: 776-787, 1999.
5. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN and Schaid DJ: Evidence for prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet 67: 82-91, 2000.
6. Tavtigian SV, Simard J, Teng DHF, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J and Cannon-Albright LA: A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 27: 172-180, 2001.
7. Carpten J, Nupponen N, Isaacs S, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein D, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y,. Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Grönberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W and Trent J: Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30: 181-184, 2002.
8. Suzuki K, Ohtake N, Nakata S, Takei T, Matsui H, Ono Y, Nakazato H, Hasumi M, Koike H, Ito K, Fukabori Y, Kurokawa K and Yamanaka H: Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population. Anticancer Res 22: 3507-3512, 2002.
9. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW and Coetzee GA: Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89: 166-170, 1997.
10. Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ and Reichardt JK: Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 10: 1077-1082, 2001.
11. Chang B, Zheng SL, Isaacs SD, Wiley KE, Carpten JD, Hawkins GA, Bleecker ER, Walsh PC, Trent JM, Meyers DA, Isaacs WB and Xu J: Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer. Int J Cancer 95: 354-359 2001.
12. Correa-Cerro L, Berthon P, Haussler J, Bochum S, Drelon E, Mangin P, Fournier G, Paiss T, Cussenot O and Vogel W: Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet 105: 281-287, 1999.
13. Hayes JD and Pulford DJ: The glutathione S-transferase supergene family: regulation of GST* and the contribution of the enzyme to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600, 1995.
14. Seidegard J, Vorachek WR, Pero RW and Pearson WR: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 85: 7293-7297, 1988.
15. Pemble S Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketterer B and Taylor JB: Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 300: 271-276, 1994.
16. Rebbeck TR: Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiolo Biomarkers Prev 6: 733-743, 1997.
17. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, Katoh T, Kamataki T, Kawamura J, Yatani R and Shirai T: Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1 glutathione s-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett 165: 171-177, 2001.
18. Sato K: Glutathione S-transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 52: 205-255, 1989.
19. Gajewska J and Szczypka M: Role of Pi form of glutathione S-transferase (GST-Pi) in cancer: a minireview. Mater Med Pol 24: 45-49, 1992.
20. Jerónimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG and Sidransky D: Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma J Natl Cancer Inst 93: 1745-1752, 2001.
21. Jerónimo C, Varzim G Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C and Sidransky D: I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Cancer Epidemiol Biomarkers Prev 11: 445-450, 2002.
22. Harries L, Stubbins MJ, Forman D, Howard GCW and Wolf CR: Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 4: 641-644, 1997.
23. Gsur A, Haidinger G, Hinteregger S, Bernhofer G, Schatzl G, Madersbacher S, Marberger M, Vutuc C and Micksche M: Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int J Cancer 95: 152-155, 2001.
24. Kote-Jarai Z, Easton D, Edwards SM, Jefferies S, Durocher F, Jackson RA, Singh R, Ardem-Jones A, Murkin A, Deamaley DP, Shearer R, Kirby R and the CRC/BPC UK familial prostate cancer study collaborators, Houlston R and Eeles R: Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer. Pharmacogenetics 11: 325-330, 2001.
25. Garca-Closas M, Kelsey KT, Hankinson SE, Spiegelman D, Springer K, Willett WC, Speizer FE and Hunter DJ: Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst 91: 1960-1964, 1999.
26. Rebbeck TR, Walker AH, Jaffe JM, White DL, Wein AJ and Mallowcz SB: Glutathione S-transferase-μ (GSTM1) and -0 (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev 8: 283-287, 1999.
27. Keladaa S, Kardia SLR, Walker AH, Wein AJ, Mallowicz and Rebbeck TR: The glutathione S-transferase-μ and -0 genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev 9: 1329-1334, 2000.
28. Autrup JL, Thomassen LH, Olsen JH, Wolf H and Autrup H: Glutathione S-transferases as risk factors in prostate cancer. Eur J Cancer Prev 8: 525-532, 1999.
29. Lewis S, Cherry NM, Niven RM, Barber P and Povey AC: GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Letters 180: 165-171, 2002.
30. Perera FP, Mooney LA, Stampfer M, Phillips DH, Bell DA, Rundle A, Cho S, Tsai WY, Ma J, Blackwood A and Tang D: Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective physicians' health cohort study. Carcinogenesis 23: 1641-1646, 2002.
31. Dekant W and Vamvakas S: Glutathione-dependent bioactivation of xenobiotics. Xenobiotica 23: 873-887, 1993.
32. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, Awasthi S and Awasthi YC: Naturally occurring human glutathione S-transferase GSTPI-1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem 224: 893-899, 1994.
33. Park JY, Schantz SP, Stern JC, Kaur T and Lazarus P: Association between glutathione S-transferase pi genetic polymorphisms and oral cancer risk. Pharmacogenetics 9: 497-504, 1999.
34. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Glutathione S-transferase M1 M3, Pl,and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10: 229-236, 2001.
35. Maugard CM, Charrier J, Pitard A, Campion L, Akande O Pleasants L and Ali-Osman F: Genetic polymorphism at the glutathione S-transferase (GST) P1 locus is a breast cancer risk modifier. Int J Cancer 91: 334-339, 2001.
36. Tsuchida S and Sato K: Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 27: 337-384, 1992.
37. Lee WH, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh WS, Isaacs WB and Nelson WG: Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 11733-11737, 1999.
38. Williams JA, Martin FL, Muir GH, Hewer A, Grober PL and Phillips DH: Metabolic activation of carcinogens and expression of various cytochrome P450 in human prostate tissue. Carcinogenesis 21: 1683-1689, 2000.
39. Sgambato A, Campisi B, Zupa A, Bochicchio A, Romano G, Tartarone A, Gialasso R, Traficante A and Cittadini A: Glutathione S transferase (GST) polymorphisms as risk factors for cancer in a highly homogenous population from Southern Italy. Anticancer Res 22: 3647-3652, 2002.